Log in
19.04.2026

Deal of the Week |

Calendar Week # 16 |

2026

Adcendo Series C: $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline

  • HQ: DK

Founded: 2017

  • Series C
  • Sector: BioTech, Pharmaceutical

Investment Raised: USD 75m €

Valuation Remains Undisclosed

Investors: The round was led Jeito Capital, with participation from additional new investors Vida Ventures, BPI France, and EIFO (Export and Investment Fund of Denmark), as well as all existing investors, including TCGX, RA Capital Management, TPG, Orbimed, Venrock, Surveyor, Logos Capital, Novo Holdings, Pontifax Venture Capital, Dawn Biopharma, a platform controlled by KKR, HealthCap, Gilde Healthcare and Ysios Capital.

News Link
27.03.2025

Deal |

2025

Novo Holdings participates in €23 million Series A for Tribune Therapeutics to advance next-generation anti-fibrotic therapies

  • HQ: SE

Founded: 2020

  • Series A
  • Sector: Pharmaceutical

Investment Raised: EUR 23m €

Valuation Remains Undisclosed

Investors: HealthCap, Industrifonden, Innovestor, Inven2, Investinor, LifeArc Ventures, Novo Holdings

News Link
19.02.2025

Deal |

2025

Latent Labs secures €47.9 million in funding to realise the potential of AI-powered, programmable biology

  • HQ: UK

Founded: 2023

  • Series A
  • Sector: Pharmaceutical

Investment Raised: USD 40m €

Valuation Remains Undisclosed

Investors: 8VC, Aidan Gomez, Flying Fish Partners, Isomer Capital, Jeff Dean, Kindred Capital, Mati Staniszewski, Pillar VC, Radical Ventures, Sofinnova Partners

News Link
20.09.2024

Deal |

2024

Brenus Pharma Raises $25 Million to Accelerate Clinical Trials of Its Precision Cancer Vaccines.

  • HQ: FR

Founded: 2014

  • Series A
  • Sector: Pharmaceutical

Investment Raised: USD 25m €

Valuation Remains Undisclosed

Investors: Angelor, Credit Agricole Centre-Est, Investsud, Jacques Gardette, Meusinvest (Noshaq), Stephane Legastelois, UI Investissement

News Link
29.02.2024

Deal |

2024

Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’

  • HQ: DK

Founded: 2022

  • Seed
  • Sector: Pharmaceutical

Investment Raised: EUR 26M €

Valuation Remains Undisclosed

Investors: Forbion Capital Partners (https://forbion.com/en/) Novo Holdings (https://novoholdings.dk/)

News Link
12.02.2024

Deal |

2024

Madrid-based LUDA Partners bags €12 million to further interconnect the digital presence of pharmacies

  • HQ: ES

Founded: 2022

  • Private Equity
  • Sector: Pharmaceutical

Investment Raised: EUR 12M €

Valuation Remains Undisclosed

Investors: Moira Capital Partners (https://moiracapitalpartners.com/)

News Link
29.03.2022

Deal |

2022

XNK Therapeutics raises SEK 132 million to accelerate growth

  • HQ: SE

Founded: 2011

  • Venture – Series Unknown
  • Sector: Pharmaceutical

Investment Raised: SEK 132M €

Valuation Remains Undisclosed

Investors: Flerie Invest (https://flerie.com/en/)

News Link
22.02.2022

Deal |

2022

Amryt Completes $125 Million Non-Dilutive Debt Refinancing

  • HQ: IR

Founded: 2012

  • Post-IPO Debt
  • Sector: Pharmaceutical

Investment Raised: USD 125M €

Valuation Remains Undisclosed

Investors: Ares Management (https://www.aresmgmt.com/)

News Link
11.05.2021

Deal |

2021

GENESIS Biomed has led the closing of a € 100,000 seed round for Telara Pharma, a spin-off from Gregorio Marañón Hospital

  • HQ: SP

Founded: 2020

  • Seed
  • Sector: Pharmaceutical

Investment Raised: EUR 0.1M €

Valuation Remains Undisclosed

Investors: GENESIS Biomed (https://www.genesis-biomed.com/)

News Link
08.03.2021

Deal |

2021

Standigm Raises $44.5M in Pre-IPO Funding

  • HQ: KR

Founded: 2015

  • Series C
  • Sector: AI, BioTech, Health Care, Pharmaceutical

Investment Raised: USD 44.5M €

Valuation Remains Undisclosed

Investors: SKS PE Daishin Private Equity (https://www.daishin.com/) SKS PE InterVest (http://intervest.co.kr/en) KDB Bank (http://www.kdbbank.eu/) Asset One Kakao Ventures (http://www.medium.com/kakaoventures) LB Investment (http://lbinvestment.com/) Atinum Investment (http://www.atinuminvest.co.kr/) DSC Investment and Wonik Investment Partners.

News Link
08.03.2021

Deal |

2021

Geneos Therapeutics Raises $12M in Series A1 Financing

  • HQ: US

Founded: 2016

  • Series A
  • Sector: BioTech, Health Care, Pharmaceutical

Investment Raised: USD 12M €

Valuation Remains Undisclosed

Investors: Korea Investment Partners (http://partners.koreainvestment.com/?lang=en&ckattempt=1) Sante Ventures and Inovio Pharmaceuticals

News Link